Table 9.

An overview of the environmental and clinical outcomes of studies using PX-UV

		Environmental outcomes			Clinical outcomes
	Micro-organism	Range of effect of all studies	Range of effect of stat. sign. findings	Number of studies	Range of effect of all studies	Range of effect of stat. sign. findings	Number of studies
Viruses	Norovirus
Bacteria	Acinetobacter				63% reduction	63% reduction	1 [89]
	CPE
	ESBL
	MRSA	72.7– 90.9% reduction	72.7–90.9% reduction	5 [69, 97, 100–102]	20% increase to 37.9% reduction	26.7–37.9% reduction	4 [89, 92, 95, 107]
	VRE	38–100% reduction	75–100% reduction	4 [69, 91, 103, 104]	18.9% increase to 52.7%	18.9–50% reduction	4 [90, 92, 93, 107]
Spores	C. difficile	59–100% reduction	63.6–94.8% reduction	3 [69, 105, 106]	18.6% increase to 53% reduction	17.2–53% reduction	8 [85, 90, 92–94, 96, 107, 108]
Yeast	C. auris